Ben Wessner - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Ben Wessner’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Health Care,
- Hospitals,
- Wellness,
- Women Founded,
- Investment Management,
- Life Science,
- Portfolio Management,
- Medical Technologies,
- Finance,
- Biotechnology,
- Medical Devices,
- Genomics,
- Health Diagnostics,
- Digital Health,
- Medical,
- Big Data,
- Information Technology,
- B2B,
- Online Portals,
- Media and Entertainment,
- Pharmaceuticals
Social media:
Past investments:
- HNI Healthcare
- Navidea Biopharmaceuticals
- Astute Medical
- T2 Biosystems
- TriVascular
- Ceterix Orthopaedics
- Omeros
- Benvenue Medical
- AFT Pharmaceuticals
- Outset Medical
- Sollis Health
- Good Start Genetics
- BioDelivery Sciences International
- Valeritas
- Intrinsic Therapeutics
- NanoString Technologies
- Endoceutics
- Harmony Biosciences
- GenomeDx Biosciences
- Bioniche Pharma Group
- Blue Belt Technologies
- TearLab Corporation
- Exagen
- Nevro
- Avinger
- Strongbridge Biopharma
- SOC Telemed
- Solta Medical
- Corium International
- Iroko Pharmaceuticals
- Cardiome Pharma
- ViewRay
- Synergy Pharmaceuticals
- Autonomic Technologies
- EndoGastric Solutions
- US WorldMeds
- Biodesix
- Silk Road Medical
- Tandem Diabetes Care
- RainDance Technologies
- Decipher Biosciences
- Earlens Corporation
- Hicuity Health, Inc.
Investor Profile
Ben Wessner is a Venture Capital, Private Equity Firm based in New York City, New York, United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems, TriVascular, Ceterix Orthopaedics, Omeros, Benvenue Medical, AFT PharmaceuticalsOutset Medical, Sollis Health, Good Start Genetics, BioDelivery Sciences International, Valeritas, Intrinsic Therapeutics, NanoString Technologies, Endoceutics, Harmony Biosciences, GenomeDx Biosciences, Bioniche Pharma Group, Blue Belt Technologies, TearLab Corporation, Exagen, Nevro, Avinger, Strongbridge Biopharma, SOC Telemed, Solta Medical, Corium International, Iroko Pharmaceuticals, Cardiome Pharma, ViewRay, Synergy Pharmaceuticals, Autonomic Technologies, EndoGastric Solutions, US WorldMeds, Biodesix, Silk Road Medical, Tandem Diabetes Care, RainDance Technologies, Decipher Biosciences, Earlens Corporation, Hicuity Health, Inc., . Over time, Ben Wessner has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Ben Wessner is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Women Founded, Investment Management, Life Science, Portfolio Management, Medical Technologies, Finance, Biotechnology, Medical Devices, Genomics, Health Diagnostics, Digital Health, Medical, Big Data, Information Technology, B2B, Online Portals, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Ben Wessner, as their portfolio suggests a familiarity and interest in this area.
Understanding Ben Wessner’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
